Keywords: fda, approves, novartis, exelon, pd, related, dementia

FDA approves Novartis' Exelon for PD related dementia

Article | 03 July 2006

Print This

The US Food and Drug Administration says that it has approved Novartis' Exelon (rivastigime) for use in the treatment of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in